Merck Sharp & Dohme LLC

Rahway, NJ ManufacturingNAICS 325410

Self-funded health planPlan year 2025Renews January
31,284Participants+1% vs. prior year
$74.2MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#3 of 76Manufacturing in NJBy participants

Overview

Merck Sharp & Dohme LLC sponsors a self-funded health plan that covered 31,284 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
31,284 · prior year 30,983
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Merck Other Group Benefits Plan, plan 501 (31,284 participants)
Broker compensation
$876K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Prudential Insurance Company of AmericaLife29,680$27.7M$400K
Life Insurance Company of North AmericaLong-term disability34,821$13.1M$285K
Continental Casualty CompanyGroup Long Term Care2,464$7.5M—
Vision Service PlanVision20,657$5.9M—
Cigna Health and Life Insurance CompanyMedical, Dental227$2.5M$61K
MetLife Legal PlansLegal6,767$1.2M$84K
Zurich American Insurance CompanyAD&D30,339$312K$47K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$74.2M/ year

Estimated prescription spend: 31,284 participants × $2,371 national average per member. Usually higher once dependents are counted.

$1.9M–$4.8M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$564K–$1.4M
Lower-cost therapeutic alternatives$823K–$1.7M
Generic pricing vs. actual cost$356K–$1.1M
PBM contract terms$185K–$556K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Merck Sharp & Dohme LLC
Sponsor EIN
22-1261880
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 22-1261880 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Merck Sharp & Dohme LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Merck Sharp & Dohme LLC.

Request a correction · Methodology